In a 13D filing on Symmetry Medical, Inc. (SMA), Blum Capital disclosed an 8.6% stake (3,059,404 shares) in the company. The firm held 1,659,404 shares at the quarter ended 12/31/07.
In a pretty standard disclosure, Blum Capital did not make any direct requests on Symmetry Medical, but said it will monitor its investment and may enter discussions with management, the Board of Directors or others. Blum may discuss ideas that, if effected, may result in any of the following: the acquisition by persons of additional Common Stock of the Issuer, an extraordinary corporate transaction involving the Issuer, and/or changes in the board of directors or management of the Issuer.
Blum Capital Partners is a $2.8 billion investment firm based in San Francisco. The firm makes strategic block and control investments in public and private transactions. The firm's investment strategy combines the private equity process applied to the public markets along with an ability to play a constructive and active role in unlocking value from portfolio companies through the implementation of financial, operational and governance initiatives.